AAKP Innovator Series: AstraZeneca, Kerry Cooper, Vice President, U.S. Medical Affairs, Renal Cardio

Sidhvi Nekkanti
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology; Cardiovascular, Renal & Metabolism; and Respiratory.
Read More